Beteiligungsmeldung
S.R. One, Limited
Declared position
3%
Threshold
Crossed upwards
Timeline
Published
21.10.2008
Transaction
25.09.2008
Übertragungsdatum
25.09.2008
Voting rights breakdown
Notice details
Meldungs-ID
T6704D6459
Beneficial owner
S.R. One, Limited
Gemeldete Adresse
S.R. One Limited, Philadelphia
S.R. One Ltd, the investment arm of GlaxoSmithKline plc, informed of reaching the threshold of 3.0% in the shareholding of Addex Pharmaceuticals Ltd. as the result of its acquisition in the market of shares. S.R. One said it had acquired a total of 175,951 registered shares, corresponding to 3.0% of the voting rights. The contact person at S.R. One is Russell Greig. S.R. One Ltd is the wholly-owned subsidiary of SmkthKline Beecham Corp., both of which are located at One Franklin Plaza, 200 N. 16th Street, Philadelphia, PA 18428 USA. SmithKline Beecham Corp is a wholly-owned subsidiary of GlaxoSmithKline Holdings (Americas) Inc., located at Wilmington Trust SP Services Inc. 1105 N. Market St., Suite 1300, Wilmington Delaware 19801 USA and a wholly-owned subsidiary of Setfirst Ltd. Setfirst Ltd* is 50.1% owned by SmithKline Beecham Holdings (U.K.) Ltd and 49.9% owned by Glaxo Wellcome Investments BV. GlaxoWellcome Investments BV (located at Huis ter Heideweg 62, 3705 LZ, Zeist, Netherlands) is a wholly-owned subsidiary of Glaxo Wellcome Holdings Ltd. Glaxo Welcome Holdings Ltd is 83.34% owned by Wellcome Ltd and 16.66% owned by Glaxo Group Ltd. Wellcome Ltd is a subsidiary of GlaxoSmithKline Finance plc. Glaxo Group Ltd (located at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, U.K.) is a wholly-owned subsidiary of GlaxoSmithKline Finance plc. SmithKline Beecham Holdings (U.K.) is a wholly-owned subsidiary of Smithkline Beecham Overseas Ltd, which in turn, is a wholly-owned subsidiary of SmithKline Beecham plc. SmithKline Beecham is a wholly-owned subsidiary of GlaxoSmithKline Finance plc, a wholly-owned subsidiary of GlaxoSmithKline Holdings Ltd. GlaxoSmithKline Holdings is a wholly-owned subsidiary of GlaxoSmithKline plc. As a result, GlaxoSmithKline plc is the ultimate beneficial owner of the shares. *Unless otherwise indicated, the entities listed in this paragraph are located at 980 Great West Road, Brentford, Middlesex, TW8 9GS, U.K.
insider24.ch
Verpassen Sie kein Marktsignal mehr
Mehr benötigt? Pro-Angebot entdecken